MicroRNAs as biomarkers of pain intensity in patients with CFS

MicroRNAs as biomarkers of pain intensity in patients with chronic fatigue syndrome, by Hadeel A Al‐Rawaf, Ahmad H Alghadir, Sami A Gabr in Pain Pract. 2019 Jul 8. doi: 10.1111/papr.12817. [Epub ahead of print]

Research abstract:

BACKGROUND:

Numerous experimental models have shown that microRNAs play an important role in regulating pain-processing in clinical pain disorders. In this study, we evaluated a set of micro-RNAs as diagnostic biomarkers of pain intensity in adolescents with chronic fatigue syndrome (CFS). We then correlated the expression of these microRNAs with the levels of inflammatory markers and pain-related comorbidities in adolescents with CSF and healthy controls (HCs).

METHODS:

A total of 150 adolescents, aged 12-18 years, participated in this study between April 2016 and April 2017. The participants were classified into two groups: adolescents with CFS (n=100) and HCs (n=50). RT-PCR was used to evaluate the expression of miR-558, miR-146a, miR-150, miR-124, and miR-143. Immunoassay analysis was used to assess the levels of immune inflammatory markers IL-6, TNF-α, and COX-2.

RESULTS:

Adolescents with CFS showed significantly higher pain thresholds than comparable non-fatigued HCs. Also, enjoy of life and relation to others as the life domains, showed lower pain interference in CFS patients. Differential expression of miR-558, miR-146a, miR-150, miR-124, and miR-143 was significantly down regulated and notably interfered with pain intensity and frequency in patients with CFS. Also, the expression of these miRNAs was significantly correlated with that of IL-6, TNF-α, and COX-2, which have been shown to mediate pain intensity in patients with CFS.

Girls with CSF showed significantly decreased expression levels of these miRNAs compared with the levels of boys with CSF. Girls with CSF also showed increased expression of inflammatory pain-related markers IL-6, TNF-α, and COX-2, compared with the levels of boys with CSF

CONCLUSIONS:

The intensity and consequences of pain were influenced by differential expression of miR-558, miR-146a, miR-150, miR-124, and miR-143, which was directly, associated with higher expression of immune inflammatory related genes TNFα, IL-6, and COX-2 in adolescences with CFS. Further studies of larger patient cohorts will help clarify the role of miRNAs in the pathogenesis of CFS.

Read full paper

 

Posted in News | Tagged , , , , , , , , , , | Comments Off on MicroRNAs as biomarkers of pain intensity in patients with CFS

Post-Exertional Malaise Is associated with hypermetabolism, hypoacetylation & purine metabolism deregulation in ME/CFS cases

Post-Exertional Malaise is associated with hypermetabolism, hypoacetylation and purine metabolism deregulation in ME/CFS cases, by Neil R McGregor, Christopher W Armstrong, Donald P Lewis and Paul R Gooley in Diagnostics 2019, 9(3), 70; [Published: 4 July 2019] https://doi.org/10.3390/diagnostics9030070

Research abstract:

Post-exertional malaise (PEM) is a cardinal predictive symptom in the definition of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). If the cases overexert themselves they have what is termed “payback” resulting in a worsening of symptoms or relapse which can last for days, weeks or even months.

The aim was to assess the changes in biochemistry associated with the cases self-reported PEM scores over a 7-day period and the frequency of reporting over a 12-month period.

Forty-seven ME/CFS cases and age/sex-matched controls had a clinical examination, completed questionnaires; were subjected to standard serum biochemistry; had their serum and urine metabolomes analyzed in an observational study.

Thirty-five of the 46 ME/CFS cases reported PEM in the last 7-days and these were allocated to the PEM group. The principal biochemical change related to the 7-day severity of PEM was the fall in the purine metabolite, hypoxanthine. This decrease correlated with alterations in the glucose:lactate ratio highly suggestive of a glycolytic anomaly. Increased excretion of urine metabolites within the 7-day response period indicated a hypermetabolic event was occurring.

Increases in urine excretion of methylhistidine (muscle protein degradation), mannitol (intestinal barrier deregulation) and acetate were noted with the hypermetabolic event. These data indicate hypoacetylation was occurring, which may also be related to deregulation of multiple cytoplasmic enzymes and DNA histone regulation.

These findings suggest the primary events associated with PEM were due to hypoacetylation and metabolite loss during the acute PEM response.

Posted in News | Tagged , , , , , , , , , , , , | 2 Comments

The clinical value of cytokines in CFS

The clinical value of cytokines in chronic fatigue syndrome, by Tiansong Yang, Yan Yang, Delong Wang, Chaoran Li, Yuanyuan Qu, Jing Guo, Tianyu Shi, Wang Bo, Zhongren Sun and Tetsuya Asakawa in Journal of Translational Medicine 2019 17:213 [Published: 28 June 2019] https://doi.org/10.1186/s12967-019-1948-6

 

Research abstract:

Chronic fatigue syndrome (CFS) is a heterogeneous disorder with uncertain pathogenesis. Without effective therapy, CFS is characterized by disabling fatigue, depression, memory loss, and somatic discomfort.

This comprehensive and impartial review aimed to assess the available evidence and examined the potential clinical value of using cytokines for the monitoring of CFS and as targets for the treatment of CFS.

Cytokines are cell signalling molecules that aid cell to cell communication in immune responses and stimulate the movement of cells towards sites of inflammation, infection and trauma.     Dr Ananya Mandal

Inflammatory reactions and immune modulation are considered to contribute to the pathophysiology of CFS, and it is well documented that cytokines present in both blood and cerebrospinal fluid (CSF) are closely associated with the progression and severity of CFS. However, pathophysiological and methodological limitations prevent using circulating cytokines as independent diagnostic indices.

Moreover, there is no evidence to support the use of CSF cytokines as independent diagnostic indices. Nevertheless, a comprehensive evaluation of changes in circulating and CSF cytokines may improve clinical understanding of the pathophysiology of patients with CFS, aiding in the establishment of an appropriate diagnosis.

Importantly, the available evidence does not support the value of cytokines as therapeutic targets. We believe that an improved understanding of cytokine-related mechanisms will be helpful to explore new cytokine-related therapeutic targets.

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on The clinical value of cytokines in CFS

Take part in a research project: health conditions & employment

Investigating the impact of health conditions on employees’ experiences of work – a research project

You are invited to take part in a research project looking into the impact explore whether having a health condition affects people’s experiences at work.

The researcher is a Masters student at Kings College London.  The survey will form part of her dissertation in  in ‘Human Resource Management and Organisational Analysis’ and she hopes it will fill an important gap in previous research.

The study:

The purpose of the study is to explore whether having a health condition affects people’s experiences at work. Specifically:

  • whether the ‘visibility’ of people’s health conditions affects things like wellbeing and experiences of discrimination at work
  • whether people tend to disclose their health conditions to their employers and colleagues
  • which factors that might predict disclosure.

Participants:

  • you should be employed and living in the UK.
  • You do not need to have a health condition to do this survey.
  • Unfortunately, this survey is not suitable for people with learning disabilities, because an Easy Read version of the survey is not available.
  • should read the information sheet before deciding to take part

The questionnaire:

  • is online
  • will take about 10-15 minutes to complete
  • will ask you questions about your job, your health and wellbeing, your experiences of discrimination at work, and how you feel about your organisation
  • nobody except the lead researcher will have access to your personal information
  • your answers will not seen by WAMES or any other organisation
  • if you volunteer to take part, you will be asked to provide your consent & can withdraw at any point
  • your data will be processed in accordance with the General Data Protection Regulation 2016 (GDPR)
  • Please read the info sheet or contact Alexia.karageorghis@kcl.ac.uk  if you have questions
  • Ethical Clearance Reference Number: HR-18/19-1051

King’s Business School, King’s College London, Bush House, Strand, London WC2R 2LS

Please share your experiences with the researcher and pass this information on so others can take part.

Posted in News | Tagged , , , , | Comments Off on Take part in a research project: health conditions & employment

The risk of labelling CFS symptoms as unhelpful cognitive responses

The risk of labelling CFS symptoms as unhelpful cognitive responses, by Michiel Tack in Clinical Child Psychology and Psychiatry 1–2 [Published June 18, 2019]  https://doi.org/10.1177/1359104519853849

 

Letter to the editor:

Loades, M. E., Rimes, K., Lievesley, K., Ali, S., & Chalder, T. (2019). Cognitive and behavioural responses to symptoms in adolescents with chronic fatigue syndrome: A case-control study nested within a cohort. Clinical Child Psychology Psychiatry. Advance online publication. doi:10.1177/1359104519835583

Loades, Rimes, Lievesley, Ali and Chalder (2019) report that unhelpful cognitive and behavioural responses to symptoms appear to be particularly prominent in adolescents with chronic fatigue syndrome (CFS). Their method to determine unhelpful responses, however, could be questioned.

Catastrophizing, for example, was assessed by how much participants agreed with statements such as ‘my illness is awful and I feel that it overwhelms me’ (Ryan, Vitoratou, Goldsmith, & Chalder, 2018). Descriptions such as these might reflect the severity of symptoms rather than the patient’s response to them. This is particularly relevant as the control group consisted of asthma patients who were less disabled than patients with CFS. Asthma patients had approximately half the score on the Chalder Fatigue Questionnaire and almost 40 points more on the Short-Form 36-item Physical Functioning Scale than patients with CFS. Anyone familiar with these scales will realize the enormous disparity in health reflected by such figures. Consequently, a direct comparison of cognitive and behavioural responses to symptoms might be misleading.

A study that did control for fatigue severity found that CFS patients showed lower levels of catastrophizing, damage beliefs and symptom focusing than patients with autoimmune rheumatic diseases (Ali, Matcham, Irving, & Chalder, 2017). In the hierarchical linear regression model by Loades et al. (2019), all of the cognitive and behavioural responses measured, explained less than 8% of the variance of fatigue at follow-up when baseline factors such as mood and fatigue were accounted for. This is contrary to the view that catastrophizing and symptom focusing are central in driving disability in CFS.

The assessment of fear avoidance is even more problematic as it is based on agreement with statements such as ‘physical activity makes my symptoms worse’ (Ryan et al., 2018). The experience of physical activity making symptoms worse is considered to be the hallmark symptom of CFS, often referred to as post-exertional malaise (Institute of Medicine, The National Academies Press, 2015). Consequently, one would expect most if not all CFS patients agree with this statement.

The National Institute for Health and Clinical Excellence (NICE) guideline, used to select
participants in the study by Loades et al., instructs clinicians to reconsider the diagnosis of CFS if patients do not experience post-exertional malaise (National Institute for Health and Care Excellence, 2007). I would therefore recommend modifying the assessment of fear avoidance in patients with CFS. Otherwise one risks measuring patients’ symptoms and mislabelling them as maladaptive cognitive responses.

Finally, Loades et al. suggest that all-or-nothing, boom-and-bust behaviour patterns exacerbate CFS symptoms in a self-perpetuating cycle. Two large studies, a Dutch (Van der Werf, Prins, Corresponding author: Vercoulen, van der Meer, & Bleijenberg 2000) and Belgian (Meeus et al., 2011) one, have tested this hypothesis using objective outcomes. Patients and healthy controls were instructed to wear an actimeter on several consecutive days to monitor their activity. Both studies found no difference in day-today fluctuations in the activity pattern between CFS patients and controls. Consequently, the view that boom-and-bust patterns of activity are perpetuating symptoms in CFS patients is unfounded.

Read full letter and references

Posted in News | Tagged , , , , , , , , , , , , | Comments Off on The risk of labelling CFS symptoms as unhelpful cognitive responses

Could you be the WAMES secretary or treasurer?

WAMES needs a new volunteer secretary and treasurer!

 

 

WAMES is very grateful to Kish and Liz for ably supporting the work of WAMES over the last few years.  Increased personal commitments mean they have had to move on.

As the posts of secretary and treasurer are critical to the running of a charity WAMES needs to find new volunteers if we are to continue campaigning, awareness raising and supporting families affected by ME in Wales.

The role of the secretary is to:

  • support the Chair in ensuring the smooth functioning of the Management Committee
  • ensure meetings are effectively organised and minuted
  • maintain effective records and administration.

The role of the treasurer is to:

  • maintain an overview of WAMES’ financial affairs and advise the committee on budgets
  • ensure that proper financial records and procedures are maintained.

To find out more contact Jan   jan@wames.org.uk

Please note:

  • These volunteering posts are for 3 years starting 1st October
  • Training can be arranged & expenses will be paid
  • Most tasks can be carried out from home
  • The posts are available as ‘role share’
  • You don’t have to be knowledgeable about ME
  • The posts will give useful experience to add to your CV

 

Posted in News | Tagged , , | Comments Off on Could you be the WAMES secretary or treasurer?

Medically documenting disability in ME/CFS cases [US]

Medically Documenting Disability in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) cases, by Barbara Comerford and Richard Podell in Front. Pediatr. 7:231, 2 July 2019 [doi: 10.3389/fped.2019.00231]

 

Article introduction:

Patients with severe myalgic encephalomyelitis/Chronic fatigue syndrome (ME/CFS) experience debilitating physical and cognitive symptoms, which often result in the need to file disability claims.

A significant number of ME/CFS patients are children or adolescents. ME/CFS patients often turn to physicians who are not trained to recognize and diagnose ME/CFS, and who might or might not understand that ME/CFS is a multi-system primarily physical illness. Such misperceptions can adversely affect the doctor-patient relationship, the clinical outcomes, as well as the results of disability claims

According to the National Academies of Science, Engineering and Medicine, “Between 836,000 and 2.5 million Americans suffer from myalgic encephalomyelitis/chronic fatigue syndrome… This disease is characterized by profound fatigue, cognitive dysfunction, sleep abnormalities, autonomic manifestations, pain, and other symptoms that are made worse by exertion of any sort. ME/CFS can severely impair patients’ ability to conduct their normal lives.1”  The prevalence of MECFS among children and adolescents has been estimated variously as between 0.11 and 4% (1).

A large percentage of children and adolescents with ME/CFS suffer from orthostatic intolerance due to one or both of these syndromes: Neurally Mediated Hypotension (NMH) and Postural Orthostatic Tachycardia Syndrome (POTS). These elements of ME/CFS often respond well to proper treatment (2, 3).

Conclusion:
The ME/CFS claimant must document the total adverse effect the constellation of symptoms has on his/her functional abilities and should provide that documentation in journal form to his treating physician during each visit. No claim can succeed without medical support and documentation of symptoms and functional limitations (physical and cognitive) by informed ME/CFS medical providers. The ME/CFS claimant medical record of functional limitations, and objective documentation of those limitations provided by the treating physician is crucial to support the ME/CFS disability claim.

If keeping a daily journal is not practical, we recommend that the patient or parent at each doctor visit submit 3 or 4 recent real life examples of episodes when the patient did “too much,” how the symptoms then flared and functional abilities declined, and how many hours or days were needed before symptoms and functional abilities regained their pre-exertional baselines.

Posted in News | Tagged , , , , , , , , | Comments Off on Medically documenting disability in ME/CFS cases [US]

Mediating relatedness for adolescents with ME: reducing isolation through minimal interactions with a robot avatar

Mediating relatedness for adolescents with ME: Reducing isolation through minimal interactions with a robot avatar, by Alma Leora Culen, Jorun Borsting, William Odom in Proceedings of the 2019 on Designing Interactive Systems Conference, Pages 359-371

Abstract:

This paper discusses how a networked object in the form of a small robot designed to mediate experiences of care, social connectedness, and intimacy, was used by adolescents with Myalgic Encephalomyelitis, a condition that reduces their normal functioning, including the ability to socialize.

A study with nine adolescents, each using the robot for about a year in average, revealed that it was largely effective at mediating their everyday experiences of relatedness, triggering productive new habits and social practices.

We interpret these findings to propose a set of strategies for designing technologies that support relatedness while requiring minimal interactivity and engagement.

Balance, extension-of-self, coolness, and acts-of-care, in addition to commonly used physicalness, expressivity and awareness, enable the robot to extend the adolescents’ ability to relate to others, people and animals.

 

Posted in News | Tagged , , , , , | Comments Off on Mediating relatedness for adolescents with ME: reducing isolation through minimal interactions with a robot avatar

Measurements of recovery & predictors of outcome in an untreated CFS sample

Measurements of recovery and predictors of outcome in an untreated Chronic Fatigue Syndrome Sample, by Marie Thomas, Andrew Smith in Journal of Health and Medical Sciences Vol 2, #2, pp 167-178 [Published online: April 22, 2019] doi:10.31014/aior.1994.02.02.33

 

Research abstract:

The current study examined a large cohort of untreated Chronic Fatigue Syndrome patients at initial assessment and at specific time points over a three-year period. Methods used in previous studies to assess patient health, were validated and used to assess recovery and improvement.

Possible predictors of outcome would then be identified by assessing improvements in health status at specific follow-up points. The illness was also assessed in terms of recovery and improvement by using health related and psychosocial measures together with the aetiology of the illness. These were further used to investigate possible mechanisms influencing or predicting recovery or improvement.

Two-hundred and twenty-six patients completed wide ranging questionnaires at initial
assessment and again six and eighteen months and three years later. A current state of health score was used to measure recovery over time and analyses conducted to investigate the relationship between this and other health related measures. Regression analyses were conducted to assess predictors of improvement and recovery.

Spontaneous recovery rates in the untreated patient at three-year follow-up were low (6%).  The data suggested, however, that illness length, symptom severity and health status have an important role in recovery. Although there was no evidence to suggest an association between illness onset type and subsequent recovery or psychopathology scores at initial assessment and recovery, regression analyses did indicate that levels of anxiety, cognitive difficulties and social support at initial assessment predict a positive outcome. The state of health measure was validated as a method of accurately assessed the health status of patients and was used as an indicator of improvement and recovery within this group.

Spontaneous recovery in the patient group was associated with several factors measured at initial assessment. However, further studies are necessary to more fully identify the factors which affect recovery or improvement and to investigate the exact nature of the mechanisms involved. The present study shows that spontaneous recovery of CFS
patients is rare. Treatment or management is essential, and the efficacy of different approaches must be assessed.

2.3.1 Measurement of Recovery

Health status and severity were measured by a ‘current state of health measure’ (Smith et al., 1996). This 5-item scale categorised the patient’s health as follows: (1) worse than at any stage of the illness; (2) bad; (3) bad with some recovery; (4) recovering with occasional relapses and (5) almost completely recovered. In order to test the validity of this measure to accurately describe health status at any given time, patients were categorised into two groups at baseline: those who were in poor health (scoring ‘worse than any stage’, ‘bad’ and ‘bad with some recovery’) and those who thought they were recovering (scoring ‘recovering with occasional relapse’ and ‘almost completely recovered’). These baseline data were then compared to measures known to be associated with the illness, including: (a) positive and negative mood (Zevon & Tellegen, 1982); (b) depression (Beck et al., 1961; Radloff, 1997); (c) anxiety (Spielberger et al., 1971); (d) fatigue related symptoms (Ray et al., 1993); (e) physical symptoms (Cohen & Hoberman, 1983; Smith et al., 1996); (f) cognitive failures (Broadbent et al., 1982) and, (g) stress (Cohen et al., 1983).

Conclusion:

Overall, the current longitudinal study has provided data indicating that prognosis for the untreated CFS patient is poor. Associations between the state of health measure and other physical and mental health variables have been verified using a large group of patients. The validation of a simple 5-item measure by other standardised measures leads us to believe that this score can be used to accurately rate patient illness severity. We have also shown that this measure can predict and assess recovery. Positive outcome measures are indicated in cases where illness length is short and when the number and severity of symptoms are low. We have confirmed the widely held belief among healthcare professionals that offering care to this patient group before the illness is allowed to become entrenched is of major importance if therapy is to be successful. The measures described here can now be used to evaluate the efficacy of treatments in future studies. Further research is necessary, however, to identify the, as yet, unidentified factors which can accurately predict positive outcome in this illness.

Posted in News | Tagged , , , , | Comments Off on Measurements of recovery & predictors of outcome in an untreated CFS sample

Monitoring treatment harm in ME/CFS: a freedom-of-information study of NHS specialist centres in England.

Monitoring treatment harm in myalgic encephalomyelitis/chronic fatigue syndrome: A freedom-of-information study of National Health Service specialist centres in England, by Graham McPhee, Adrian Baldwin, Tom Kindlon, Brian M Hughes in J Health Psychol. 2019 Jun 24. [Epub ahead of print] doi:10.1177/1359105319854532

 

Research abstract:

The use of graded exercise therapy and cognitive behavioural therapy for myalgic encephalomyelitis/chronic fatigue syndrome has attracted considerable controversy.

This controversy relates not only to the disputed evidence for treatment efficacy but also to widespread reports from patients that graded exercise therapy, in particular, has caused them harm.

We surveyed the National Health Service–affiliated myalgic encephalomyelitis/ chronic fatigue syndrome specialist clinics in England to assess how harms following treatment are detected and to examine how patients are warned about the potential for harms.

We sent 57 clinics standardised information requests under the United Kingdom’s Freedom of Information Act.

Data were received from 38 clinics.

Clinics were highly inconsistent in their approaches to the issue of treatment-related harm.

They placed little or no focus on the potential for treatment-related harm in their written information for patients and for staff.

Furthermore, no clinic reported any cases of treatment-related harm, despite acknowledging that many patients dropped out of treatment.

In light of these findings, we recommend that clinics develop standardised protocols for anticipating, recording, and remedying harms, and that these protocols allow for therapies to be discontinued immediately whenever harm is identified.

Read full paper

Posted in News | Tagged , , , , , , , , | Comments Off on Monitoring treatment harm in ME/CFS: a freedom-of-information study of NHS specialist centres in England.